Podcasts

TOGA Podcast 41

This episode is hosted by: Dr Pei Ni Ding, Dr Samantha Bowyer, and Mr Naveed Alam.

Decoding Perioperative Immunotherapy In NSCLC

Episode Summary

In this TOGA podcast, we provide an overview of the recent neoadjuvant, adjuvant, and perioperative IO data, the options and considerations for treatment, and the current reimbursement landscape.

Show Hosts

This episode’s host are:

  • Dr Pei Ni Ding, Medical Oncologist from Westmead and Nepean Hospitals Sydney
  • Dr Samantha Bowyer, Medical Oncologist from Sir Charles Gairdner Hospital in Perth
  • Mr Naveed Alam, Thoracic Surgeon from St Vincents, Epworth and Monash in Melbourne

Show links

Many emerging treatments are discussed in this podcast, and clinicians are reminded that oncology access programs are listed in the medicines access portal

Sponsor

This episode is proudly sponsored by MSD. 

 

Play TOGA Podcast 41

More Podcasts

A conversation with Associate Professor Tom John and Professor Ben Solomon where they discuss the increased survival benefits for patients with oncogene driven lung cancer
In this Podcast, Mark Scott talks with Alexandra Golledge about her challenges in diagnosis, searching for the best treatments available, living in a regional area
Prof Nick Pavlakis and Prof Emily Stone join discuss the remarkable advances in screening, diagnosing and treating lung cancer that occurred during 2020.
Dorothy Keefe, CEO of Cancer Australia and Mark Scott discuss the COVID impact on diagnosing and treating lung cancer patients.
A fireside chat with Prunella Blinman, Shankar Siva and our three Preceptees: Anna Lawless, Abhijit Pal and Melanie Rabbets about their experiences, their learnings, what
In this episode, Prof Anna Nowak and A/Prof Steven Kao discuss the emerging treatments for mesothelioma patients and the DREAM3R trial.